Acorda Therapeutics, Inc.
(NASDAQ : ACOR)

... ...
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -1.47%131.020.0%$2314.17m
BNGOBioNano Genomics, Inc. 18.50%9.800.0%$2016.46m
GILDGilead Sciences, Inc. -0.06%66.941.0%$649.72m
AMGNAmgen, Inc. 0.58%253.501.3%$564.60m
CRSPCRISPR Therapeutics AG 1.83%188.490.6%$487.99m
REGNRegeneron Pharmaceuticals, Inc. 0.43%537.782.7%$478.09m
ALXNAlexion Pharmaceuticals, Inc. 1.19%159.732.0%$470.59m
NVAXNovavax, Inc. 3.74%126.9892.9%$417.43m
ILMNIllumina, Inc. 0.34%406.253.5%$396.72m
SRPTSarepta Therapeutics, Inc. 1.36%98.2413.8%$364.79m
VRTXVertex Pharmaceuticals, Inc. -0.44%237.591.9%$361.85m
BIIBBiogen, Inc. -0.25%269.441.7%$321.90m
BNTXBioNTech SE 2.86%108.440.0%$298.33m
EXASEXACT Sciences Corp. 1.30%150.0019.6%$243.95m
PACBPacific Biosciences of California, Inc. 3.06%37.427.4%$228.17m

Company Profile

Acorda Therapeutics, Inc. engages in the development of therapies that restore function and improve the lives of people with neurological disorders. Its products include AMPYRA (dalfampridine), INBRIJA (levodopa inhalation powder), BTT1023 (timolumab), SYN120, rHIgM22, and GGF2 (Cimaglermin alfa). The company was founded by Ronald Cohen in 1995 and is headquartered in Ardsley, NY.